The DOI matches its Crossref record; 192 of the 192 references it cites were found in a registry or an index.
Perfluoroalkyl and polyfluoroalkyl substances (PFAS) and their effects on the ovary
Open accessAbstract
BACKGROUND: Perfluoroalkyl and polyfluoroalkyl substances (PFAS) are found widespread in drinking water, foods, food packaging materials and other consumer products. Several PFAS have been identified as endocrine-disrupting chemicals based on their ability to interfere with normal reproductive function and hormonal signalling. Experimental models and epidemiologic studies suggest that PFAS exposures target the ovary and represent major risks for women’s health. OBJECTIVE AND RATIONALE: This review summarises human population and toxicological studies on the association between PFAS exposure and ovarian function. SEARCH METHODS: A comprehensive review was performed by searching PubMed. Search terms included an extensive list of PFAS and health terms ranging from general keywords (e.g. ovarian, reproductive, follicle, oocyte) to specific keywords (including menarche, menstrual cycle, menopause, primary ovarian insufficiency/premature ovarian failure, steroid hormones), based on the authors’ knowledge of the topic and key terms. OUTCOMES: Clinical evidence demonstrates the presence of PFAS in follicular fluid and their ability to pass through the blood–follicle barrier. Although some studies found no evidence associating PFAS exposure with disruption in ovarian function, numerous epidemiologic studies, mostly with cross-sectional study designs, have identified associations of higher PFAS exposure with later menarche, irregular menstrual cycles, longer cycle length, earlier age of menopause and reduced levels of oestrogens and androgens. Adverse effects of PFAS on ovarian folliculogenesis and steroidogenesis have been confirmed in experimental models. Based on laboratory research findings, PFAS could diminish ovarian reserve and reduce endogenous hormone synthesis through activating peroxisome proliferator-activated receptors, disrupting gap junction intercellular communication between oocyte and granulosa cells, inducing thyroid hormone deficiency, antagonising ovarian enzyme activities involved in ovarian steroidogenesis or inhibiting kisspeptin signalling in the hypothalamus. WIDER IMPLICATIONS: The published literature supports associations between PFAS exposure and adverse reproductive outcomes; however, the evidence remains insufficient to infer a causal relationship between PFAS exposure and ovarian disorders. Thus, more research is warranted. PFAS are of significant concern because these chemicals are ubiquitous and persistent in the environment and in humans. Moreover, susceptible groups, such as foetuses and pregnant women, may be exposed to harmful combinations of chemicals that include PFAS. However, the role environmental exposures play in reproductive disorders has received little attention by the medical community. To better understand the potential risk of PFAS on human ovarian function, additional experimental studies using PFAS doses equivalent to the exposure levels found in the general human population and mixtures of compounds are required. Prospective investigations in human populations are also warranted to ensure the temporality of PFAS exposure and health endpoints and to minimise the possibility of reverse causality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Buck, R. C., Franklin, J., Berger, U., Conder, J. M., Cousins, I. T., de Voogt, P., Jensen, A. A., Kannan, K., Mabury, S. A., & van Leeuwen, S. P. (2011) · Integrated Environmental Assessment and Management · doi:10.1002/ieam.258 · Cited by 4,641
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
Diamanti-Kandarakis, E., Bourguignon, J.-P., Giudice, L. C., Hauser, R., Prins, G. S., Soto, A. M., Zoeller, R. T., & Gore, A. C. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0002 · Cited by 4,585
Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism*
Desvergne, B., & Wahli, W. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.5.0380 · Cited by 3,086
Braissant, O., Foufelle, F., Scotto, C., Dauça, M., & Wahli, W. (1996) · Endocrinology · doi:10.1210/endo.137.1.8536636 · Cited by 2,217
Olsen, G. W., Burris, J. M., Ehresman, D. J., Froehlich, J. W., Seacat, A. M., Butenhoff, J. L., & Zobel, L. R. (2007) · Environmental Health Perspectives · doi:10.1289/ehp.10009 · Cited by 2,049
Organofluorine Chemistry: Principles and Commercial Applications
(1994) · doi:10.1007/978-1-4899-1202-2 · Cited by 1,691
Fluorinated Surfactants and Repellents
(2001) · Textile Research Journal · doi:10.1177/004051750107100823 · Cited by 1,369
Norman, R. J., Dewailly, D., Legro, R. S., & Hickey, T. E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61345-2 · Cited by 1,360
Estrogen Actions in the Central Nervous System1
McEwen, B. S., & Alves, S. E. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0365 · Cited by 1,358
Hu, X. C., Andrews, D. Q., Lindstrom, A. B., Bruton, T. A., Schaider, L. A., Grandjean, P., Lohmann, R., Carignan, C. C., Blum, A., Balan, S. A., et al. (2016) · Environmental Science & Technology Letters · doi:10.1021/acs.estlett.6b00260 · Cited by 1,333
Research works printed but not linked: 9
- 2018, Toxicological profile for perfluoroalkyls
- Bradley, 2007, Investigation into the migration potential of coating materials from cookware products, Food Addit Contam, 24, 326, 10.1080/02652030601013711 · doi:10.1080/02652030601013711
- 2019, National Report on Human Exposure to Environmental Chemicals
- 2009, Fourth Report on Human Exposure to Environmental Chemicals
- Fedail, 2014, Roles of thyroid hormones in follicular development in the ovary of neonatal and immature rats, Endocrine, 46, 594, 10.1007/s12020-013-0092-y · doi:10.1007/s12020-013-0092-y
- 2020, PFAS Fact Sheets
- Parazzini, 1996, Menopause, menstrual and reproductive history, and bone density in northern Italy, J Epidemiol Community Health, 50, 519, 10.1136/jech.50.5.519 · doi:10.1136/jech.50.5.519
- Wong, 2014, Enhanced elimination of perfluorooctane sulfonic acid by menstruating women: evidence from population-based pharmacokinetic modeling, Environ Sci Technol, 48, 8807, 10.1021/es500796y · DOI · Paper page
- Xie, 2017, Maternal exposure to perfluorooctanoic acid inhibits luteal function via oxidative stress and apoptosis in pregnant mice, Reprod Toxicol, 69, 159, 10.1016/j.reprotox.2017.02.010 · DOI
Cited by
PFAS Molecules: A Major Concern for the Human Health and the Environment
Panieri, E., Baralic, K., Djukic-Cosic, D., Buha Djordjevic, A., & Saso, L. (2022) · Toxics · doi:10.3390/toxics10020044 · Cited by 651
Brase, R. A., Mullin, E. J., & Spink, D. C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22030995 · Cited by 374
Leung, S. C. E., Wanninayake, D., Chen, D., Nguyen, N.-T., & Li, Q. (2023) · Science of The Total Environment · doi:10.1016/j.scitotenv.2023.166764 · Cited by 288
Lee, Y. J., Jung, H. W., Kim, H. Y., Choi, Y.-J., & Lee, Y. A. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.683297 · Cited by 96
Wang, B., Yao, Y., Wang, Y., Chen, H., & Sun, H. (2022) · Environmental Science & Technology · doi:10.1021/acs.est.0c08242 · Cited by 91
Metadata
- Authors
- Ding, N., Harlow, S. D., Randolph Jr, J. F., Loch-Caruso, R., & Park, S. K.
- Venue
- Human Reproduction Update
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-05-29
- Volume
- 26
- Issue
- 5
- Pages
- 724-752
- ISSN
- 1355-4786 (ISSN-L)
- 1460-2369
- OpenAlex
- W3031831327
- Cited by
- 400
- References
- 192
- FWCI
- 12.17
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Funders
- National Institute of Environmental Health Sciences
- NIEHS
- National Institutes of Health
- NIH (R01 ES026578, R01 ES026964, P30 ES017885)
- National Institute for Occupational Safety and Health
- Centers for Disease Control and Prevention (T42 OH008455)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Perfluoroalkyl and polyfluoroalkyl substances (PFAS) and their effects on the ovary. https://app.cochat.ai/papers/10.1093/humupd/dmaa018
- The paper
- Ding, N., Harlow, S. D., Randolph Jr, J. F., Loch-Caruso, R., & Park, S. K. (2020). Perfluoroalkyl and polyfluoroalkyl substances (PFAS) and their effects on the ovary. Human Reproduction Update. https://doi.org/10.1093/humupd/dmaa018
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.